Patients who received tranexamic acid prior to total shoulder arthroplasty had a statistically significant reduction in blood loss and had shorter recovery room and hospital stays than controls, according to results.
Researchers compared 106 patients undergoing primary anatomic or reverse total shoulder arthroplasty (TSA) who received a 20 mg/kg dose of tranexamic acid intravenously with 88 patients who did not receive tranexamic acid. The morning after TSA, researchers collected a blood sample from all patients for a hemoglobin and hematocrit determination.
Source: Healio
Read more